Torrent Pharma Q4 net at Rs 357 cr

Image
Press Trust of India New Delhi
Last Updated : May 23 2016 | 7:58 PM IST
Torrent Pharma today reported consolidated net profit of Rs 357 crore for the quarter ended March 31, mainly on account of robust sales in the US market.
It had posted net profit of Rs 130 crore for the January- March period of the previous fiscal, the company said in a BSE filing.
Total income from operations stood at Rs 1,499 crore for the quarter under consideration, compared with Rs 1,154 crore for the year-ago period.
For the entire 2015-16 fiscal, the consolidated net profit of the company was at Rs 1,722 crore. It was Rs 751 crore in the year-ago fiscal.
Total income from operations stood at Rs 6,676 crore last fiscal. It was Rs 4,653 crore for the previous fiscal.
"The figures for the quarter ended December 31, 2015 and March 31, 2016 are after giving effect of scheme of amalgamation while figures for the corresponding quarters are before giving effect of amalgamation," Torrent Pharma said.
Hence, the figures of the corresponding period and previous year are not comparable with the figures of the current period, it added.
In a separate filing, the company said its board after considering the distribution of interim dividend and special interim dividend of Rs 20 and Rs 15 (total Rs 35 per share) respectively per equity share of Rs 5 each for the financial year 2015-16, did not recommend distribution of any further dividend.
Torrent Pharma stock closed 0.77 per cent higher at Rs 1,333.55 on BSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 23 2016 | 7:58 PM IST

Next Story